Biosimilars 4: Physician's Perspectives of Biosimilars

This fourth course in the Biosimilars Continuing Education Series entitled "Physician's Perspectives of Biosimilars", gastroenterologist Ralph Mckibbin, MD shares physician perspectives on key issues surrounding biosimilars. These include physician confidence level in biosimilars, thoughts on when and how they are substituted, and who should control treatment decisions

After completing this module, the participant should be able to:

1. Describe physician confidence levels surrounding biosimilar safety and efficacy
2. Identify key concerns of physicians related to non-medical switching of biologics/biosimilars
3. Compare physician perspectives on physician-led vs third-party-led biosimilar switches
4. Explain the effects of an FDA designation of “interchangeable” on physician confidence with biosimilar prescribing and switching
5. Characterize the attitudes of U.S. physicians regarding FDA policy on biologic and biosimilar nomenclature

The College of Pharmacy at The Ohio State University is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education. This program is approved for 1.0 contact hours (0.1 CEU) under the ACPE universal program number 0633-0000-22-035-H99-P. Participants must view the video, achieve an 80% on the quiz and complete the evaluation to receive CE credit for program. Questions about pharmacist's participation in the program and continuing education credit should be addressed to Brooke Keber at cop-cpd@osu.edu.